SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: George Antoniou who wrote (630)5/28/1999 9:39:00 PM
From: Street Walker  Read Replies (1) of 5582
 
GUMM...as time goes by, its getting more interesting.

Citadel Financing closure will be a big milestone.

They are developing a nicorette gum - their number 1 priority.

The Common Cold Season is a few months away and GUMM
is positioning itself to accomodate the orders of Zicam.

GUMM is a sleeping giant. When it awakens' shareholders will
be more than pleasantly suprised.

I believe we are about to eliminate the current resistance areas
and move up the support on the bids. In otherwords, the train is about to leave the station. Everyone here is aboard!

Message 9372766

SW
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext